Ignite Creation Date:
2025-12-24 @ 5:06 PM
Ignite Modification Date:
2026-01-13 @ 1:19 PM
Study NCT ID:
NCT02841150
Status:
COMPLETED
Last Update Posted:
2018-03-29
First Post:
2016-06-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Assess the Bioequivalence of Ibrutinib 560- Milligram (mg) Tablet to Four 140 -mg IMBRUVICA Capsules
Sponsor:
Janssen Research & Development, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-06
Start Date Type:
ACTUAL
Primary Completion Date:
2016-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-08
Completion Date Type:
ACTUAL
First Submit Date:
2016-06-15
First Submit QC Date:
None
Study First Post Date:
2016-07-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-03-28
Last Update Post Date:
2018-03-29
Last Update Post Date Type:
ACTUAL